SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-078885
Filing Date
2022-12-12
Accepted
2022-12-12 06:01:13
Documents
12
Period of Report
2022-12-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea169958-8k_allarity.htm   iXBRL 8-K 27989
  Complete submission text file 0001213900-22-078885.txt   201819

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE allr-20221209.xsd EX-101.SCH 3227
3 XBRL LABEL FILE allr-20221209_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE allr-20221209_pre.xml EX-101.PRE 22359
6 EXTRACTED XBRL INSTANCE DOCUMENT ea169958-8k_allarity_htm.xml XML 3714
Mailing Address 22 SCHOOL STREET, 2ND FLOOR BOSTON MA 02108
Business Address 22 SCHOOL STREET, 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 221456054
SIC: 2834 Pharmaceutical Preparations